Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)

NCT05996406 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Light Chain (AL) Amyloidosis
CCND1 Translocation
Venetoclax

Interventions

DRUG: Venetoclax
DRUG: Dexamethasone Oral

Sponsor

Peking Union Medical College Hospital